NAVB - Navidea Biopharmaceuticals Inc
Previous close
0.001
0 0%
Share volume: 1,836,193
Last Updated: Thu 29 Aug 2024 06:00:00 AM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$0.00
0.00
0.00%
View ratios
Fiscal Date | 2022-03-31 | 2022-06-30 | |
---|---|---|---|
Fiscal Quarter | Q1 2022 | Q2 2022 | |
Report Date | 2022-05-16 | 2022-08-15 | |
Cash flow financing | -339.453 K | 1.371 M | |
Other financing cash flows | 0.000 | 0.000 | |
Cash flow | -2.556 M | -2.139 M | |
Net income | -2.987 M | -2.999 M | |
Depreciation | 53.232 K | 21.771 K | |
Changes in inventories | 322.992 K | 315.670 K | |
Changes in receivables | 115.845 K | 30.069 K | |
Investing Cashflow | -118.192 K | -121.192 K | |
Net Borrowings | -1.771 M | -104.696 K | |
Investing Activity Other | 0.000 | 0.000 | |
Dividends Paid | 0.000 | 0.000 | |
Exchange Rate Effect | 0.000 | 0.000 | |
Capital Expenditures | -118.192 K | -121.192 K | |
Cash Change | 1.217 M | 328.012 K |